Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Elisa A. Rozeman, Judith M. Versluis, Karolina Sikorska, Ruben Lacroix, Lindsay G Grijpink-Ongering, Birthe Heeres, Bart A. Van De Wiel, Petros Dimitriadis, Ayşegül Sari, Stijn Heijmink, Pia Kvistborg, Daan van den Broek, Annegien Broeks, Jan Willem de Groot, Sofie Wilgenhof, Marieke Anne Vollebergh, Johannes V. Van Thienen, John B. A. G. Haanen, Christian U. Blank | ||||||||||||
Title | The IMPemBra trial, a phase II study comparing pembrolizumab with intermittent/short‐term dual MAPK pathway inhibition plus pembrolizumab in melanoma patients harboring the BRAFV600 mutation. | ||||||||||||
|
|||||||||||||
URL | https://meetinglibrary.asco.org/record/186980/abstract | ||||||||||||
Abstract Text | J Clin Oncol 38: 2020 (suppl; abstr 10021); DOI: 10.1200/JCO.2020.38.15_suppl.10021 |